Growing burden of cancer, rising demand for personalized medicine, and increasing collaborations to co-develop drug and diagnostic technologies are key factors driving market growth   The global oncology companion diagnostics market size is expected to reach USD 6.60 Billion by 2028 and register a CAGR of 13% over the forecast period, according to the latest report...